Quick Answer
TherapeuticsMD, Inc. reported Stockholders Equity of $26.88 million for fiscal year 2025.
TherapeuticsMD, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $26.88M | -1.8% |
| 2024 | $27.37M | -6.5% |
| 2023 | $29.29M | -16.7% |
| 2022 | $35.14M | +137.5% |
| 2021 | -$93.62M | +24.5% |
| 2020 | -$124.00M | -1447.7% |
| 2019 | $9.20M | -90.6% |
| 2018 | $97.52M | -24.9% |
| 2017 | $129.91M | +1.9% |
| 2016 | $127.49M | +102.2% |
| 2015 | $63.06M | +30.3% |
| 2014 | $48.39M | -11.5% |
| 2013 | $54.70M | +3916.7% |
| 2012 | -$1.43M | +16.3% |
| 2011 | -$1.71M | -277.5% |
| 2010 | $964.4K | +99.4% |
| 2009 | $483.6K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $27.44M | +1.3% | +0.6% |
| June 30, 2025 | $27.29M | -1.4% | +2.1% |
| March 31, 2025 | $26.74M | -6.7% | -2.3% |
| December 31, 2024 | $27.37M | -6.5% | +1.0% |
| September 30, 2024 | $27.09M | -3.4% | -2.1% |
| June 30, 2024 | $27.67M | -11.3% | -3.5% |
| March 31, 2024 | $28.66M | -10.5% | -2.1% |
| December 31, 2023 | $29.29M | -16.7% | +4.4% |
- TherapeuticsMD, Inc. showed a decrease of -1.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, TherapeuticsMD, Inc.’s stockholders equity has grown by 5457.1% (from $483.6 thousand to $26.88 million).
- The most recent figure is from TherapeuticsMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: